- Home
- KROS vs BLW Comparison
KROS vs BLW Comparison
Compare KROS & BLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- BLW
- Stock Information
- Founded
- KROS 2015
- BLW 2003
- Country
- KROS United States
- BLW United States
- Employees
- KROS N/A
- BLW N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- BLW Other Consumer Services
- Sector
- KROS Health Care
- BLW Consumer Discretionary
- Exchange
- KROS Nasdaq
- BLW Nasdaq
- Market Cap
- KROS 460.6M
- BLW 506.7M
- IPO Year
- KROS 2020
- BLW N/A
- Fundamental
- Price
- KROS $11.00
- BLW $14.34
- Analyst Decision
- KROS Buy
- BLW
- Analyst Count
- KROS 11
- BLW 0
- Target Price
- KROS $45.33
- BLW N/A
- AVG Volume (30 Days)
- KROS 2.1M
- BLW 85.9K
- Earning Date
- KROS 02-26-2025
- BLW 01-01-0001
- Dividend Yield
- KROS N/A
- BLW 8.83%
- EPS Growth
- KROS N/A
- BLW N/A
- EPS
- KROS N/A
- BLW 1.81
- Revenue
- KROS $651,000.00
- BLW N/A
- Revenue This Year
- KROS $303.27
- BLW N/A
- Revenue Next Year
- KROS N/A
- BLW N/A
- P/E Ratio
- KROS N/A
- BLW $7.73
- Revenue Growth
- KROS 8037.50
- BLW N/A
- 52 Week Low
- KROS $9.78
- BLW $12.35
- 52 Week High
- KROS $73.00
- BLW $14.26
- Technical
- Relative Strength Index (RSI)
- KROS 24.79
- BLW 58.58
- Support Level
- KROS $11.04
- BLW $14.21
- Resistance Level
- KROS $11.99
- BLW $14.35
- Average True Range (ATR)
- KROS 0.60
- BLW 0.11
- MACD
- KROS 1.20
- BLW 0.02
- Stochastic Oscillator
- KROS 43.99
- BLW 93.68
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About BLW Blackrock Limited Duration Income Trust
Blackrock Ltd Duration Income Trust is a diversified investment fund with an investment objective to provide current income and capital appreciation. The Fund's portfolio normally has an average portfolio duration of less than five years. The Fund may invest directly in such securities or synthetically through the use of derivatives.